Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema
NCT02949726Phase 1Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2017
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by UTHealth Houston. Primary endpoints: Lymphatic propulsive velocity as assessed by NIRFLI, Lymphatic propulsive frequency as assessed by NIRFLI and 3 more. Started Apr 2017; status: completed.
Beyond the preview
Go deeper on NCT02949726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949726.